Suppr超能文献

“现状评估” 2021 年安全药理学学会杰出服务奖:回顾过去,应对未来挑战。

"Appraisal of state-of-the-art" The 2021 Distinguished Service Award of the Safety Pharmacology Society: Reflecting on the past to tackle challenges ahead.

机构信息

UCB-Biopharma SRL, Early Solutions, Development Science, Non-Clinical Safety Evaluation, Braine L'Alleud, Belgium.

UCB-Biopharma SRL, Early Solutions, Development Science, Non-Clinical Safety Evaluation, Braine L'Alleud, Belgium.

出版信息

J Pharmacol Toxicol Methods. 2023 Sep-Oct;123:107269. doi: 10.1016/j.vascn.2023.107269. Epub 2023 May 5.

Abstract

This appraisal of state-of-the-art manuscript highlights and expands upon the thoughts conveyed in the lecture of Dr. Jean-Pierre Valentin, recipient of the 2021 Distinguished Service Award of the Safety Pharmacology Society, given on the 2nd December 2021. The article reflects on the strengths, weaknesses, opportunities, and threats that surrounded the evolution of safety and secondary pharmacology over the last 3 decades with a particular emphasis on pharmaceutical drug development delivery, scientific and technological innovation, complexities of regulatory framework and people leadership and development. The article further built on learnings from past experiences to tackle constantly emerging issues and evolving landscape whilst being cognizant of the challenges facing these disciplines in the broader drug development and societal context.

摘要

这篇最新文献述评突出并扩展了 2021 年安全药理学学会杰出服务奖获得者 Jean-Pierre Valentin 博士在 2021 年 12 月 2 日演讲中传达的思想。本文回顾了过去 30 年中安全药理学和次要药理学发展所面临的优势、劣势、机遇和威胁,特别强调了药物开发交付、科学技术创新、监管框架的复杂性以及人员领导和发展。本文进一步借鉴了过去的经验教训,以应对不断出现的问题和不断变化的格局,同时意识到这些学科在更广泛的药物开发和社会背景下面临的挑战。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验